September 12, 2016
A key drug review committee of the Ministry of Health, Labor and Welfare (MHLW) supported approval of MSD’s anti-PD-1 antibody pembrolizumab, known as Keytruda overseas, on September 9. The Pharmaceutical Affairs and Food Sanitation Council’s Second Committee on Drugs, a...read more